ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk weight-loss drug reduces cardiovascular events as well, study finds
Novo Nordisk weight-loss drug reduces cardiovascular events as well, study finds
Announcement as on 08 August 2023

Novo Nordisk to double India manufacturing, bring new drugs by 2025
Plans to bring new drugs by 2025 into the country, which is part of all its global clinical trials
Announcement as on 20 June 2023

: Novo Nordisk cracks down on alleged Ozempic imitations
Drug maker Novo Nordisk NVO on Tuesday sued five wellness spas and clinics in federal court, accusing them of unlawfully peddling what they said were modified copies of the popular drug Ozempic and other medications being used for weight loss, according to
Announcement as on 20 June 2023

Novo Nordisk's Smash-Hit Drug Could Become Even More Profitable. Here's Why.
Novo Nordisk's (NYSE: NVO) semaglutide is everywhere in the news, and for good reason. Thanks to its ability to help people lose weight and control their diabetes symptoms, its moneymaking potential is practically off the charts. And there's a preliminary
Announcement as on 05 June 2023

: Novo Nordisk in talks to buy controlling stake in Biocorp
Novo Nordisk NVO has entered into exclusive negotiations to acquire a controlling stake in French medical device maker Biocorp in a deal that values Biocorp at 154.4 million euros, or about 5 million, the companies said in a release. The companies have
Announcement as on 05 June 2023

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 38.53
  • 12Day Average: 38.23
  • 20Day Average: 38.3
  • 50Day Average: 42.53
  • 100Day Average: 44.78
  • 150Day Average: 43.55
  • 200Day Average: 45

NVO Indicators & signals

Indicator MACD (12,26,9)

38.59, 39.69, -1.46
Indicator MACD is in negative zone

Indicator ADX (14)

11.54, 23.23, 29.29
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
19 Mon Oct 2026 38.41 38.35 to 39.15 -1.08% 0.51 times
16 Fri Oct 2026 38.83 38.67 to 39.40 -0.99% 0.96 times
15 Thu Oct 2026 39.22 38.89 to 39.68 2.89% 1.31 times
14 Wed Oct 2026 38.12 37.90 to 38.42 0.16% 0.83 times
13 Tue Oct 2026 38.06 37.98 to 38.89 -1.35% 0.82 times
12 Mon Oct 2026 38.58 38.26 to 38.85 -0.16% 0.78 times
09 Fri Oct 2026 38.64 38.06 to 38.68 1.2% 0.86 times
08 Thu Oct 2026 38.18 37.51 to 38.23 -0.21% 1.05 times
07 Wed Oct 2026 38.26 37.51 to 38.47 1.95% 1.21 times
06 Tue Oct 2026 37.53 36.85 to 37.53 -0.08% 1.22 times
05 Mon Oct 2026 37.56 36.46 to 37.76 0.64% 0.95 times
02 Fri Oct 2026 37.32 37.17 to 37.65 -0.24% 0.91 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top